Latest Molecular neuroscience Stories
UCLA chemists and molecular biologists have for the first time used a "structure-based" approach to drug design to identify compounds with the potential to delay or treat Alzheimer's disease, and possibly Parkinson's, Lou Gehrig's disease and other degenerative disorders.
Researchers have found that the brains of patients with early-onset Alzheimer's produce about 20 percent more of a protein fragment known as amyloid beta 42 than family members without the disease.
For several years, the pharmaceutical industry has tried to develop drugs that target a specific neurotransmitter receptor in the brain, the NMDA receptor.
Johns Hopkins researchers have identified a rare gene mutation in a single family with a high rate of schizophrenia, adding to evidence that abnormal genes play a role in the development of the disease.
One of the mechanisms involved in human hearing is similar to the operation of a car battery, according to a new study by researchers at the University of Iowa.
Jackson Laboratory researchers led by Associate Professor Zhong-wei Zhang, Ph.D., have provided direct evidence that a specific neurotransmitter receptor is vital to the process of pruning synapses in the brains of newborn mammals.
Alzheimer's disease is one of the most common causes of dementia.
- The act of sweetening by admixture of some saccharine substance.